key: cord-0834406-kowo6dt4
authors: Zheng, Zhong; Yao, Zhixian; Wu, Ke; Zheng, Junhua
title: The Diagnosis of SARS‐CoV2 Pneumonia: A Review of Laboratory and Radiological Testing Results
date: 2020-05-28
journal: J Med Virol
DOI: 10.1002/jmv.26081
sha: 70d0611564fe6640be8e9d0d2d900265a1da29b2
doc_id: 834406
cord_uid: kowo6dt4

The rapid emergence of COVID‐19 (coronavirus disease 2019) has necessitated the implementation of diverse pandemic control strategies throughout the world. In order to effectively control the spread of this disease, it is essential that it be diagnosed at an early stage so that patients can be reliably quarantined such that disease spread will be slowed. At present, the diagnosis of this infectious form of coronavirus pneumonia is largely dependent upon a combination of laboratory testing and imaging analyses of variable diagnostic efficacy. In the present report, we reviewed prior literature pertaining to the diagnosis of different forms of pneumonia caused by coronaviruses (SARS, MERS, and SARS‐CoV‐2) and assessed two different potential diagnostic approaches. We ultimately found that computed tomography (CT) was associated with a higher rate of diagnostic accuracy than was a real‐time quantitative polymerase chain reaction (qPCR)‐based approach (P = 0.0041), and chest radiography (P = 0.0100). Even so, it is important that clinicians utilize a combination of laboratory and radiological testing where possible in order to ensure that this virus is reliably and quickly detected such that it may be treated and patients may be isolated in a timely fashion, thereby effectively curbing the further progression of this pandemic. This article is protected by copyright. All rights reserved.

offering density specificity that enables a rapid assessment of lung lesions and the latter offering better spatial specificity as it allows clinicians to directly evaluate transverse lung sections, as well as surrounding tissues and vasculature 51 .

Chest radiography is generally the first test to be ordered in patients suspected to be suffering from SARS, MERS, or COVID-19. With the advancing technology, artificial intelligence (AI) system could surve as a reliable support 52 . In such radiographs, 72% of SARS patients were found to exhibit abnormalities (78% consolidation, 33% ground-glass opacity [GGO]) 35 49 53-57 . Similarly, 86% of MERS patients exhibit radiographic abnormalities (65% GGO, 18% consolidation, 17% bronchovascular markings, 11% air bronchogram, 4% diffuse reticulonodular patterning) [58] [59] [60] [61] [62] [63] [64] [65] [66] . In COVID-19 patients, chest radiographic abnormalities have been observed in 62% of patients (27% GGO, 47% consolidation, and 1% pneumothorax) 12 45 46 67-71 . There were no significant differences in rates of radiographic abnormalities among these three coronavirus infections (P = 0.1827).

The spatial location of lesions in coronavirus pneumonia patients is also an important diagnostic and prognostic consideration. SARS patients exhibited unilateral and bilateral involvement in 61% and 39% of cases, respectively, with 55% and 45% of patients exhibiting single and multiple infiltration, respectively, and with the lower lung being more susceptible to infection (74% of patients) 35 56 57 . Unilateral and bilateral involvement was observed in 40% and 60% of MERS patients, respectively, with 40% and 60% of patients similarly exhibiting single and multiple infiltration, respectively, and with interstitial infiltration having been detected in 67% of patients 64 65 72 . Unilateral and bilateral involvement has been detected in 29% and 71% of COVID-19 patients, respectively, with these patients exhibiting single, multiple, and interstitial infiltration in 48%, 52%, and 7% of cases, respectively, and with the lower lung being susceptible to infection (50% of patients) 45 68 69 . These results suggest that COVID-19 and MERS are more commonly associated with bilateral lung involvement relative to SARS, whereas SARS and MERS are associated with similar infiltration rates.

Overall, extant radiographic data suggest that chest radiography can aid in the diagnosis of coronavirus pneumonia, although there is still potential for misdiagnosis. As such, further CT scans are important in affected patients. (Table 3) CT scans are increasingly common diagnostic tools owing to recent advances in lowdose and high-resolution imaging techniques, with, similar to chest radiography, AI system involving 46 73 . In CT scans, 98% of SARS patients were found to exhibit abnormalities, with 81% exhibiting GGO, 49% exhibiting consolidation, 87% exhibiting interlobular septal thickening, 74% exhibiting crazy paving pattern, and 4% exhibiting parapneumonic effusion 56 57 74 . In contrast, 100% of MERS patients were found to exhibit CT abnormalities (86% GGO, 65% consolidation, 38% pleural effusion, 35% interlobular septal thickening) 65 As CT scans offer excellent spatial specificity, they can be more effectively used to assess lesion variability than can radiographic scans. CT scans of SARS patients identified 61% and 39% of lesions as being unifocal and multifocal, respectively, with 74% and 26% being unilobar and multilobar, respectively, 48% being unilateral, 52% being bilateral, 71% exhibiting lower lobe involvement, and 84% exhibiting peripheral or subpleural involvement 56 57 74 . In contrast, just 14% of MERS lesions were found to be unilateral, with the remaining 86% being bilateral, and with 14% exhibiting lower lobe involvement and 71% being peripheral or subpleural 65 75 . Unifocal and multifocal lung lesions were observed in 31% and 69% of COVID-19 patients, respectively, with unilobar and multilobar lesions being detected in 25% and 75% of patients, respectively, and with 21% and 79% exhibiting unilateral and bilateral involvement, respectively, in addition to 56% exhibiting lower lobe involvement, 79% exhibiting peripheral or subpleural involvement, and 71% exhibiting central involvement 45 78-84 90 . In line with chest radiographic findings, these results suggest that MERS and COVID-19 are associated with more diffuse disease than is SARS, potentially due to underlying differences in the pathological mechanisms of these diseases. Overall, data suggest that CT scans offer markedly higher diagnostic efficacy relative to chest radiography (P = 0.0100). However, CT scans cannot reliably identify infections This article is protected by copyright. All rights reserved.

associated with a specific virus, nor can they reliably differentiate between viruses 88 . Even so, owing to their excellent diagnostic utility, CT scans should be the primary mode of imaging examination in patients with suspected coronavirus pneumonia.

Present guidelines indicate that formal SARS-CoV-2 diagnosis is dependent upon the results of laboratory examinations such as swab test qPCR analyses 97 . However, such laboratory testing is both time-and resource-intensive, with test kits and swabs not being available in sufficient quantities in some areas of rapid viral spread. These diagnostic approaches are also hampered by the potential for false-negative results due to laboratory errors or a lack of a sufficiently highquality sample for analysis 42 98 .

In order to aid in the more precise diagnostic evaluation of patients with coronavirus pneumonia, we herein compared extant data pertaining to abnormal CT findings and qPCR results in this disease context. While no significant differences between CT and qPCR findings were observed for MERS patients owing to the relatively limited literature surrounding this emerging virus (P = 0.3516), significant differences between CT and qPCR results were observed for both SARS and COVID-19 cases (P = 0.0302, P = 0.0041) ( Table 4 ). While qPCR analyses can achieve 100% specificity 22 44 47 , in order to do so they require access to a sufficient viral specimen. While bronchoalveolar lavage fluid (BALF) samples were associated with a 100% viral positivity rate in one study, sputum samples were associated with a lower positivity rate (74.4 -88.9%), while nasal swab detection rates were lower still (53.6 -73.3%) 44 . This may be a consequence of a number of different factors pertaining to sample collection methodology, timing, sample transport, and sample testing parameters. Lower respiratory samples have the potential to offer greater diagnostic sensitivity even when nasopharyngeal and oropharyngeal qPCR tests yield negative results, and serological testing should also be used as a follow-up approach in those with clinically suspected disease 17 . It is also vital that clinicians implement appropriate infection control strategies for all patients with suspected disease, including patients that exhibit negative qPCR findings but that exhibit imaging signs consistent with coronavirus pneumonia 17 . A single swab-based test is also not sufficient to reliably rule out the possibility of infection. In a study of MERS patients, while only 89% of patients were found to be positive after a single swab test, 96.5% were found to be positive following two consecutive swabs, and 97.6% were positive following three consecutive swab tests 39 . Initial negative test results have a high risk of being false-negative findings, and repeated testing is therefore essential in order to ensure appropriate patient quarantine and management.

With respect to CT scans, the relatively low rates of COVID-19 misdiagnosis (3.9%) suggest that radiologic diagnoses may be a reliable means of quickly detecting cases of coronavirus pneumonia so as to facilitate rapid and effective patient quarantine and management 88 . An AI study related to CT scan achieved a test accuracy of 96% (95% CI: 90-98%), sensitivity 95% (95% CI: 83-100%) and specificity of 96% (95% CI: 88-99%) with Receiver Operating Characteristic Accepted Article (ROC) AUC of 0.95 and Precision-Recall (PR) AUC of 0.90, which concluded that AI assistance improved radiologists' performance in distinguishing COVID-19 from non-COVID-19 pneumonia on chest CT 99 . These scans may also be of value in patients that initially exhibit negative PCR findings. For example, Xie et al. 42 reported on five patients that were negative for SARS-CoV-2 in initial qPCR tests, but that exhibited typical COVID-19 CT findings including GGO and consolidation. These patients were isolated, and subsequent repeated qPCR testing eventually confirmed all five of these patients to be infected with SARS-CoV-2 42 . Similarly, research conducted by Ai et al. 43 revealed that positive chest CT findings were detected in 75% of symptomatic patients with negative qPCR findings. Serial RT-PCR and CT scans in these patients suggested a mean interval of 5.1 ± 1.5 days between initial negative qPCR and positive qPCR findings 43 . The comprehensive strategy reached a higher sensitivity of 94% in a retrospective study (Table 4 ) 46 .

While CT scans expose patients to higher radiation doses, the relative risks and benefits of such exposure must be determined by radiologists and clinicians. In the context of severe pandemic disease, CT scans are a valuable tool and may be essential in order to accurately and quickly identify and isolate COVID-19 patients. However, a combination of both laboratory testing and imaging is essential in order to accurately identify COVID-19 patients with confidence, and CT scans should be ordered in patients with negative qPCR results that are nonetheless suspected to be suffering from coronavirus pneumonia. When patients test positive for SARS-CoV-2 infection, while there is a small risk of false-positive diagnosis, it is essential that they be strictly isolated from other individuals in order to limit the ability of this virus to spread through vulnerable communities.

In summary, in the present review we surveyed the results of prior studies of SARS, MERS, and COVID-19 patients in an effort to establish which diagnostic approaches are most efficacious in those with coronavirus pneumonia. While we found that CT scans are associated with higher detection rates than are qPCR tests, it is nonetheless important that clinicians utilize a combination of imaging and laboratory findings to inform their diagnostic process such that patients can be rapidly identified and quarantined, thus stemming the spread of these deadly pandemic viruses. This article is protected by copyright. All rights reserved. RT-PCR = reverse transcription-polymerase chain reaction. qPCR = real-time quantitative reverse transcription-polymerase chain reaction.

# There was only one study related the serological test of MERS.

*Lack of data. 

Coronaviruses: a paradigm of new emerging zoonotic diseases

A novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan

Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

World Health Organization

Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation area

Serological assays for emerging coronaviruses: challenges and pitfalls

Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis

Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Pointof-Care Assays: a Paradigm Shift to Molecular Tests

A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland

Serologic and molecular biologic methods for SARSassociated coronavirus infection

Coronavirus as a possible cause of severe acute respiratory syndrome

Early diagnosis of SARS coronavirus infection by real time RT-PCR

Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore

Middle East respiratory syndrome coronavirus intermittent positive cases: Implications for infection control

Verification and diagnostic evaluation of the RealStar((R)) Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0

Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study

Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Early X-ray and CT appearances of severe acute respiratory syndrome: an analysis of 28 cases

Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients

Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia

Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients

Hospital outbreak of Middle East respiratory syndrome coronavirus

Clinical implication of radiographic scores in acute Middle East respiratory syndrome coronavirus pneumonia: Report from a single tertiary-referral center of South Korea

CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus

Descriptive epidemiology and characteristics of confirmed cases of Middle East respiratory syndrome coronavirus infection in the Makkah Region of Saudi Arabia

Emerging Coronavirus 2019-nCoV Pneumonia

Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes

CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan

Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults

COVID-19): Role of Chest CT in Diagnosis and Management

Accepted Article Parapneumonic effusion:4% Bilateral:52% Peripheral or subpleural:84% Lower lobe

86% Consolidation: 52% Pleural effusion: 38% Interlobular thickening: 35% Unilateral:14% Bilateral:86% Peripheral or subpleural:71% Lower lobe

GGO: 82% Consolidation: 45% Interlobular septal thickening: 48% Air bronchogram: 35% Bronchus distortion: 18% Pleural effusion: 6% Pleural thickening: 47% Pleural retraction sign: 33% Reticular pattern: 63% Vacuolar sign: 55% Microvascular dilation sign: 45% Fibrotic streaks: 37% Unifocal: 31% Multifocal: 69% Unilobar: 25% Multilobar: 75% Unilateral: 21% Bilateral: 79% Peripheral or subpleural: 79% Central: 71%